The new reagents include the first-ever commercially available synthetic single guide RNAs for CRISPRi, as well as a patent-pending, dCas9-SALL1-SDS3 repressor available in mRNA and lentiviral ...

A single “best solution ... for improved in vivo transfection methods, especially for RNA interference,” she added. “To advance as a therapeutic, RNAi reagents must be able to reliably ...

The SBiB reagent enables researchers to incorporate multiple initiators anywhere in a DNA or RNA sequence during solid-phase synthesis. Previously it was only feasible to incorporate a single ...